BRIEF-Janssen Research & Development submits supplemental application to FDA to update prescribing information for Xarelto
April 28, 2017 at 16:46 PM EDT
* Janssen Research & Development says it has submitted supplemental new drug application to u.s. Fda to update prescribing information for xarelto